Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: May 21, 2025 to May 27, 2025
Business Overview: CCEP is a leading consumer goods company operating in 31 countries, serving nearly 600 million consumers. The company is listed on Euronext Amsterdam, NASDAQ, the London Stock Exchange, and Spanish Stock Exchanges.
Key Financial Metrics and Capital Allocation
Note: This filing reports on share repurchase activities and does not contain operational financial statements (revenue, profit, cash flow, or margins).
- Share Buyback Programme: The Company is executing a programme to repurchase up to EUR 1 billion of ordinary shares.
- First Tranche Status: Completed on May 23, 2025. The maximum aggregate amount for this tranche was EUR 275,000,000.
- Second Tranche Details:
- Commencement: May 27, 2025.
- Duration: Expected to run until August 7, 2025.
- Maximum Amount: EUR 205,000,000.
- London Venue Allocation: Up to EUR 55,000,000 (expected completion by July 31, 2025).
- Share Treatment: All repurchased shares are cancelled.
Material Changes and Transaction Details
The filing details specific share repurchase transactions executed on US Trading Venues (Nasdaq) via Goldman Sachs. No purchases were made on London Trading Venues during this specific reporting window.
| Date of Purchase | Shares Purchased | Lowest Price (USD) | Highest Price (USD) | VWAP (USD) |
|---|---|---|---|---|
| May 20, 2025 | 30,755 | 88.1400 | 88.8700 | 88.4772 |
| May 21, 2025 | 30,545 | 88.3500 | 89.1500 | 88.8061 |
| May 22, 2025 | 30,719 | 88.3200 | 89.2600 | 88.7229 |
| May 23, 2025 | 27,685 | 88.0900 | 89.6000 | 88.9703 |
Material Change: The first tranche of the buyback programme was fully completed on May 23, 2025, triggering the commencement of the second tranche on May 27, 2025.
Guidance, Outlook, and Risks
- Outlook: The Company expects the second tranche of the buyback programme to cover the period from May 27, 2025, to August 7, 2025.
- Management Commentary: The purpose of the programme is to reduce the issued share capital of the Company. Purchases are made independently and uninfluenced by the Company under contracts with Goldman Sachs.
- Risks and Contingencies: The filing includes a standard cautionary note regarding forward-looking statements. Actual results may differ materially due to risks outlined in the "Risk Factors" section of the 2024 Annual Report on Form 20-F (filed March 21, 2025).
- Unusual Items: None reported in this filing.
Key Facts for Investor Verification
- Verify the total cumulative amount spent on the first tranche (EUR 275 million) against the company's cash position in the most recent quarterly report.
- Confirm the exact start date of the second tranche (May 27, 2025) and monitor subsequent 6-K filings for execution progress.
- Review the 2024 Annual Report on Form 20-F for detailed risk factors referenced in the forward-looking statements.
- Note that all repurchased shares are cancelled, directly impacting the total share count and potentially earnings per share (EPS).
- Observe that recent trading activity has been concentrated on US Trading Venues, with no London venue purchases reported in this specific week.